World Mitochondria Society awarded Nanolive for their New Technology in the Visualisation of Mitochondria
World Mitochondria Society is honored to award Nanolive for their new technology, the Holotomographic Phase Imaging or Short Nanolive Imaging, presented during Targeting Mitochondria 2019, which was held in Berlin, Germany.
The Nanolive Imaging allows the visualization of Mitochondria without any staining or labeling, it requires ~ 100 times less energy than light-sheet microscopes. Moreover, with a resolution below 200 nm, it enables high resolution and high-frequency imaging even with sensitive material, giving access to organelle dynamics that were previously out of reach.
The Scientific Committee would like to thank Dr. Jamin Jung for his excellent talk on the non-invasive live cell imaging overcomes phototoxicity problem while imaging cellular and mitochondrial processes, presented during Targeting Mitochondria 2019.
Testimonial of Marlies Muernseer, Field Application Specialist, from Nanolive:
"The Targeting Mitochondria Conference 2019 was an excellent venue and allowed us to interact with scientists from around the world and discuss Nanolive’s imaging techniques to image mitochondria fine dynamics. The large amount of interesting talks covered the whole field and gave deep insights into upcoming and unpublished facets of cutting-edge research. We want to thank for the excellent organisation and venue."
For media information
Media center: World Mitochondria Society
Contact: www.targeting-mitochondria.com
KLOX Technologies Inc. awarded during Targeting Mitochondria 2019
During Targeting Mitochondria 2019, KLOX Technologies Inc. have received the Innovation Award for their study on the assessment of the effect of Fluorescent Light Energy (FLE) on mitochondria dynamics.
The Scientific Committee thanks KLOX Technologies Inc. for their talk entitled "Effects of fluorescent light energy on mitochondria dynamics" presented during Targeting Mitochondria 2019. Their study showed that FLE decreased total mitochondria number and increased single mitochondria volume, likely due to fusion events that reversed "small sphere" mitochondria and restored the mitochondria network (morphology) to a complex, branched network.
Testimonial of Dr. Michela Zago, Manager and Senior Research Associate of KLOX Technologies Inc.:
"Our team at Klox Technologies was particularly excited about attending this Congress as its focus is well in line with our effort to target distressed mitochondria using our Fluorescent Light Energy Biomodulation technology. Klox was impressed by the quality of the speakers and the depth of the topics as well as humbled by the receipt of the 2019 Innovation Award"
For media information
Media center: World Mitochondria Society
Contact: www.targeting-mitochondria.com
World Mitochondria Society awarded Minovia during Targeting Mitochondria 2019
The Scientific Committee of Targeting Mitochondria 2019 is honored to discern the Innovation Award to Minovia for their clinical study on the Mitochondria Augmentation Therapy.
The study performed by Minovia and presented during Targeting Mitochondria 2019 "Mitochondria augmentation therapy (MAT): mitochondrial enrichment of hematopoietic stem cells in patients with mitochondrial disease", suggest that MAT can diminish disease progression in patients with mtDNA disorders.
For media information
Media center: World Mitochondria Society
Contact: www.targeting-mitochondria.com
World Mitochondria Society would like to thank Biolog
World Mitochondria Society Team would like to thank Biolog for their support and participation during Targeting Mitochondria 2019, which was held in Berlin, Germany in October.
Biolog had a booth during the two days of conference, and a talk presented by Dr. Barry R. Bochner from Biolog on their news assays plates, the MitoPlate I-1TM, which has a triplicate repeat of 30 energy producing substrates and the MitoPlate S-1TM, which has 22 inhibitors of mitochondrial function titrated at 4 dilutions. Using these new assays Dr. Bochner shows that mitochondria from different cell types exhibit different functional properties.
For media information
Media center: World Mitochondria Society
Contact: www.targeting-mitochondria.com
The organizers of Targeting Mitochondria 2019 would like to thank MitoQ
The organizers thank MitoQ for their support and participation at the Targeting Mitochondria 2019.
MitoQ also supports the presentation of Prof. Douglas Seals, from the University of Colorado Boulder, USA, on the mitochondria antioxidant therapy for treating vascular aging.
For media information
Media center: World Mitochondria Society
Contact: www.targeting-mitochondria.com
A honor for Targeting Mitochondria 2019 to welcome Prof. Douglas Wallace
It was a great honor to welcome Prof. Douglas Wallace, Member of the National Academy of Science since 1995, during Targeting Mitochondria 2019, for his excellent talk entitled "A Mitochondrial Etiology of the Common Complex Diseases".
The World Mitochondria Society would like to thank Prof. Wallace for his participation.
For media information
Media center: World
Mitochondria Society
Contact: www.targeting-mitochondria.com
"Kissing nano-tunnels" by Patricia Morcillo
"Kissing nano-tunnels" is a beautiful image submitted to the World Mitochondria Society by Patricia Morcillo, from Albert Einstein College of Medicine, in New York, USA, and selected by the Scientific Committee for the 10th anniversary of Targeting Mitochondria congress.
As described by Patricia Morcillo, mitochondrial communication is lost after exposure to manganese-induced Parkinsonism.
"Beautiful anomaly" by Sonja Lehmann
"Beautiful anomaly", submitted by Sonja Lehmann, from the Intitute of Molecular and Cellular Anatomy, in Aachen, Germany, is the second image selected by the Scientific Committee of Targeting Mitochondria 2019 for the 10th anniversary.
Immortalized human keratinocytes derived from patients with the hereditary skin disease Pachyonychia congenita were transfected with MitoTimer. Confocal live-cell imaging revealed the bizarre mitochondrial morphology that rarely occurs in atypical cells.
